Stefan Fichtner-Feigl
Department of Surgery
University of Regensburg
Franz-Josef-Strauss-Allee 11
Regensburg
Germany
Name/email consistency: high
- Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation. Boehm, F., Martin, M., Kesselring, R., Schiechl, G., Geissler, E.K., Schlitt, H.J., Fichtner-Feigl, S. BMC. Gastroenterol (2012)
- Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice. Jauch, D., Martin, M., Schiechl, G., Kesselring, R., Schlitt, H.J., Geissler, E.K., Fichtner-Feigl, S. Gut (2011)
- Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis. Fichtner-Feigl, S., Strober, W., Geissler, E.K., Schlitt, H.J. Mucosal. Immunol (2008)
- Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2. Fichtner-Feigl, S., Terabe, M., Kitani, A., Young, C.A., Fuss, I., Geissler, E.K., Schlitt, H.J., Berzofsky, J.A., Strober, W. Cancer Res. (2008)
- Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. Fichtner-Feigl, S., Fuss, I.J., Young, C.A., Watanabe, T., Geissler, E.K., Schlitt, H.J., Kitani, A., Strober, W. J. Immunol. (2007)
- Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides. Fichtner-Feigl, S., Fuss, I.J., Preiss, J.C., Strober, W., Kitani, A. J. Clin. Invest. (2005)